News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
O'Toole David D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4
| O'Toole David D (CFO) has filed a Form 4 on AVITA Medical, Inc.|
Txns:
| Bought 1,000 shares
@ $17.05, valued at
$17.1k
Bought 1,000 shares
@ $17.06, valued at
$17.1k
|
|
| 08/15/2023 |
4
| O'Toole David D (CFO) has filed a Form 4 on AVITA Medical, Inc.|
Txns:
| Bought 1,000 shares
@ $17.92, valued at
$17.9k
Bought 1,000 shares
@ $17.89, valued at
$17.9k
Bought 1,000 shares
@ $17.96, valued at
$18k
Bought 1,000 shares
@ $17.94, valued at
$17.9k
Bought 1,000 shares
@ $17.93, valued at
$17.9k
|
|
| 06/16/2023 |
4
| O'Toole David D (CFO) has filed a Form 4 on AVITA Medical, Inc.|
Txns:
| Granted 150,000 options to buy
@ $17, valued at
$2.6M
|
|
| 06/16/2023 |
3
| O'Toole David D (CFO) has filed a Form 3 on AVITA Medical, Inc. |
| 03/03/2023 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 22,512 shares
@ $20, valued at
$450.2k
Disposed/sold 11,736 shares
@ $20, valued at
$234.7k
Granted 2,000 shares
@ $0
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 33,000 options to buy
@ $13.61, valued at
$449.1k
Disposed/sold 8,250 options to buy
@ $13.6, valued at
$112.2k
Disposed/sold 10,750 options to buy
@ $12.15, valued at
$130.6k
|
|
| 01/31/2023 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 541 shares
@ $20.26, valued at
$11k
|
|
| 01/09/2023 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 415 shares
@ $20.2, valued at
$8.4k
|
|
| 01/05/2023 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,600 shares
@ $20.2, valued at
$32.3k
|
|
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2022 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 432 shares
@ $30.6, valued at
$13.2k
|
|
| 01/05/2022 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2021 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Bought 600 shares
@ $15.38, valued at
$9.2k
|
|
| 01/27/2021 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 2,450 shares
@ $0
Granted 5,400 shares
@ $0
Granted 10,750 options to buy
@ $12.15, valued at
$130.6k
|
|
| 06/11/2020 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Bought 1,000 shares
@ $8.74, valued at
$8.7k
|
|
| 05/26/2020 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Bought 1,000 shares
@ $11, valued at
$11k
|
|
| 01/09/2020 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 4,150 shares
@ $0
Granted 8,250 options to buy
@ $13.6, valued at
$112.2k
|
|
| 11/26/2019 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Bought 100 shares
@ $13.22, valued at
$1.3k
|
|
| 11/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2019 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Bought 1,000 shares
@ $15.2, valued at
$15.2k
|
|
| 08/13/2019 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Bought 1,000 shares
@ $15.46, valued at
$15.5k
|
|
| 01/04/2019 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 33,000 options to buy
@ $13.61, valued at
$449.1k
|
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2018 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Bought 3,000 shares
@ $18.85, valued at
$56.6k
|
|
| 01/08/2018 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 13,200 options to buy
@ $24.84, valued at
$327.9k
|
|
| 09/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/19/2016 |
4
| O'Toole David D (See Remarks) has filed a Form 4 on Capnia, Inc.|
Txns:
| Bought 2,000 shares
@ $1.01, valued at
$2k
|
|
| 08/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/06/2013 |
4
| O'Toole David D (SVP & CFO) has filed a Form 4 on CODEXIS INC|
Txns:
| Paid exercise price by delivering 4,697 shares
@ $1.76, valued at
$8.3k
|
|
|
|
|